|
Variable
|
β
|
Standard Error
|
Chi-Square
|
P
|
HR(95% CI)
|
|---|
|
Age group
|
−0.72
|
0.43
|
2.83
|
0.0923
|
0.49(0.21 ~ 1.13)
|
|
Menopause
|
0.76
|
0.44
|
3.00
|
0.0835
|
2.14(0.9 ~ 5.06)
|
|
Stage (early or late)
|
1.48
|
0.39
|
14.63
|
0.0001*
|
4.40(2.06 ~ 9.4)
|
|
Histotype
|
−0.36
|
0.28
|
1.69
|
0.1941
|
0.7(0.4 ~ 1.2)
|
|
Lymph node positive
|
0.11
|
0.38
|
0.09
|
0.7667
|
1.12(0.53 ~ 2.36)
|
|
Lymphadenectomy
|
0.43
|
0.33
|
1.73
|
0.1887
|
1.54(0.81 ~ 2.95)
|
|
Residual disease
|
0.51
|
0.28
|
3.47
|
0.0625
|
1.67(0.97 ~ 2.87)
|
|
CA125 normal
|
0.68
|
0.56
|
1.51
|
0.219
|
1.98(0.67 ~ 5.89)
|
|
Tumor side
|
0.29
|
0.27
|
1.17
|
0.2797
|
1.34(0.79 ~ 2.28)
|
|
Endometriosis
|
−0.39
|
0.47
|
0.70
|
0.4038
|
0.68(0.27 ~ 1.69)
|
|
Chemotherapy course
|
−0.78
|
0.28
|
7.61
|
0.0058*
|
0.46(0.26 ~ 0.8)
|
|
Chemoresistance
|
1.94
|
0.32
|
37.68
|
<.0001*
|
6.96(3.75 ~ 12.93)
|
|
Hypertension
|
0.77
|
0.30
|
6.61
|
0.0102*
|
2.16(1.2 ~ 3.89)
|
- *the difference reached statistical significance. P values were cultivated by Cox regression analysis. The overall test of the above model showed the model was significance, p < 0.0001
